Ben J Cohlen

ORCID: 0000-0003-1405-7780 · 4 papers in corpus · active 2006-2025

Study types

  • article 2
  • other 2

Condition tags

  • endometriosis 3
  • infertility 1
other 2025
Long-term risk of endometrial cancer after assisted reproductive technology
Human Reproduction ·doi:10.1093/humrep/deaf018

STUDY QUESTION: What is the risk of endometrial cancer after long-term follow-up in women treated with ART between 1983 and 2001 compared with women in the general population and subfertile women who did not undergo ART? SUMMARY ANSWER: Th…

other 2021
Agents for ovarian stimulation for intrauterine insemination (IUI) in ovulatory women with infertility
The Cochrane database of systematic reviews ·doi:10.1002/14651858.CD005356.pub3

BACKGROUND: Intrauterine insemination (IUI), combined with ovarian stimulation (OS), has been demonstrated to be an effective treatment for infertile couples. Several agents for ovarian stimulation, combined with IUI, have been proposed, bu…

article 2011
The addition of GnRH antagonists in intrauterine insemination cycles with mild ovarian hyperstimulation does not increase live birth rates--a randomized, double-blinded, placebo-controlled trial
Human Reproduction ·doi:10.1093/humrep/der033

BACKGROUND: This multicenter, double-blinded RCT investigated the efficacy of GnRH antagonists in cycles with mild ovarian hyperstimulation (MOH) followed by IUI in subfertile women. METHODS: Couples diagnosed with unexplained, male factor …

article 2006
A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility
·doi:10.1093/humrep/del441

BACKGROUND: Controlled ovarian hyperstimulation with intrauterine insemination (IUI) is a widely accepted treatment for unexplained and male subfertility. No consensus exists about the drug of first choice to be used as hyperstimulation. Th…